Medicines in Development for Mental Illness: 2010 Report

PhRMA April 25, 2013

America’s pharmaceutical research and biotechnology companies are currently developing 313 medicines to help the nearly 60 million American adults today suffering from some form of mental illness— from Alzheimer’s disease to depression and from schizophrenia to addictive disorders, such as dependence on alcohol or drugs. All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration.